| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | Koenig Sheldon L.60 | President And CEO | Sell | 30,474 | $1.11 | $33,795.67 | -1.9% | +155.0% | +190.8% | |
| Jun 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 7,229 | $1.15 | $8,327.81 | -1.5% | +155.0% | +190.8% | |
| Apr 17, 2025 | Warren Eric60 | Chief Commercial Officer | Sell | 108 | $0.98 | $105.62 | - | +17.9% | - | |
| Apr 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 8 | $0.96 | $7.71 | - | +17.9% | - | |
| Mar 18, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 3,535 | $1.48 | $5,242.41 | -0.7% | -25.9% | +58.9% | |
| Mar 18, 2025 | Warren Eric60 | Chief Commercial Officer | Sell | 2,433 | $1.49 | $3,617.87 | -0.7% | -25.9% | +58.9% | |
| Mar 18, 2025 | Koenig Sheldon L.60 | President And CEO | Sell | 13,047 | $1.50 | $19,622.69 | -0.8% | -25.9% | +58.9% | |
| Feb 19, 2025 | Warren Eric60 | Chief Commercial Officer | Sell | 239 | $1.87 | $446.45 | -0.1% | -52.2% | +85.3% | |
| Feb 19, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 11 | $1.86 | $20.46 | - | -52.2% | +85.3% | |
| Jan 17, 2025 | Halladay Benjamin | Chief Financial Officer | Sell | 9 | $2.27 | $20.39 | - | -57.0% | +37.6% |